[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-354895-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-354895-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","differential-roles-of-rad18-in-repressing-carcinogen-and-oncogene-driven-mutagenesis-in-vivo","Differential roles of Rad18 in repressing carcinogen-and oncogene-driven mutagenesis in vivo","","RAD18, a DNA repair protein, activates Y-family trans-lesion synthesis (TLS) polymerases that tolerate DNA damage but can be error-prone, and its overexpression is common in cancer. The study tests how Rad18 status shapes chemically induced and oncogene-driven tumorigenesis. In 4NQO oral carcinogenesis, Rad18 induction occurs before OSCCs; chronic exposure accelerates tumor onset in Rad18−/− mice, with higher G(C)>T(A) transversions. RAD18 deficiency does not alter KrasG12D lung tumorigenesis or mutations, supporting context-specific tumor-suppressive activity.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/differential-roles-of-rad18-in-repressing-carcinogen-and-oncogene-driven-mutagenesis-in-vivo/354895/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/differential-roles-of-rad18-in-repressing-carcinogen-and-oncogene-driven-mutagenesis-in-vivo/354895.png","ImageObject",300,407,{"name":42,"@type":43},"Patrick","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does RAD18 influence DNA damage tolerance during replication?","Question",{"text":63,"@type":64},"RAD18 activates Y-family trans-lesion synthesis (TLS) DNA polymerases, enabling replication across DNA damage. This process can be error-prone, affecting mutation outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What effect does Rad18 deficiency have in the chemically induced oral carcinogenesis model?",{"text":68,"@type":64},"In the 4NQO oral model, chronic treatment accelerates tumor onset in Rad18−/− mice versus Rad18+/+ animals. OSCC exomes show increased G(C)>T(A) transversions in Rad18−/− tumors.",{"name":70,"@type":61,"acceptedAnswer":71},"Does Rad18 deficiency change oncogene-driven lung tumorigenesis in the KrasG12D model?",{"text":72,"@type":64},"No. Rad18 deficiency does not affect rates or incidence of oncogene-induced lung tumors or the associated mutations in this model.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},354895,1790880340,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","NAR Cancer, 2026, 8, zcag001  \n[https://doi.org/10.1093/narcan/zcag001](https://doi.org/10.1093/narcan/zcag001)  \nDNA Damage Sensing and Repair  \nDifferential roles of Rad18 in repressing carcinogen-and oncogene-driven mutagenesis in vivo  \nJay R. Anand 1 , Bethany Wagner Brown1 , Jitong Lou2 , Qisheng Gu3 , Yang Yang1 , Gaith Droby4 , Di Wu3 , Akankshya Jena 1 , Jialiu Xie2 , Yuri Fedoriw 1 , Bernard Weissman 1 , Scott Williams1,5 ,* , Cyrus Vaziri 1,4,5 ,*  \n1 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States  \n2 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States  \n3 Division of Oral and Craniofacial Health Sciences, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States  \n4 Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, NC 27599, United States  \n5 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, United States  \n∗ To whom correspondence should be addressed. Email: [cyrus_vaziri@med.unc.edu](cyrus_vaziri@med.unc.edu)  \nCorrespondence may also be addressed to Scott Williams. Email: [scott_williams@med.unc.edu](scott_williams@med.unc.edu)  \nAbstract  \nThe DNA repair protein RAD18 activates “Y-family” trans-lesion synthesis (TLS) DNA polymerases that are DNA damage-tolerant and potentially error-prone. RAD18 is also frequently overexpressed and pathologically activated in cancer cells. However, the extent to which RAD18 shapes cancer genomes and impacts tumorigenesis is unclear. Therefore, we tested the effect of Rad18 status on chemically induced and oncogenedriven tumorigenesis. In a chemically induced oral carcinogenesis model, acute (2–16 days) 4NQO treatment induces expression of Rad18 and TLS polymerase mRNAs in mouse oral epithelial cells prior to the emergence of oral squamous cell carcinomas (OSCCs) . Chronic (8-week) 4NQO treatment leads to the onset of oral tumors that is accelerated in Rad18−/ − mice when compared with Rad18+/+ animals. Analysis of OSCC exomes reveals increased levels of G(C)>T(A) transversions in Rad18−/ − tumors when compared with Rad18+/+ . Therefore, Rad18 promotes error-free bypass of 4NQO-induced DNA lesions and suppresses 4NQO-induced oral carcinogenesis. In a KrasG12D-induced lung carcinogenesis model, Rad18 deficiency did not affect rates or incidence of oncogene-induced lung tumors or mutations. Taken together, we demonstrate that Rad18 has context-specific tumor-suppressive activity. Given the prevalence of 4NQO-like environmental exposures, RAD18 is highly likely to shape human cancer genomes and perhaps influence other aspects of the tumorigenic process.  \nGraphical abstract  \nIntroduction  \nDNA damage and DNA repair are intimately connected with all phases of cancer. Carcinogenesis is often initiated by environmental genotoxic exposures ([e.g. solar](e.g. solar) radiation, tobacco smoke) . Error-prone replication or repair of damaged DNA  \nKRASG12D  \nLung Adenocarcinoma Model  \nWild type  \nTumorigenesis  \nRAD18 -/ -  \nUnchanged tumorigenesis and mutagenesis  \ncan induce mutations in growth-regulatory genes and incite multistep carcinogenesis [1–3]. The efficiency and fidelity with which carcinogen-induced DNA damage is repaired directly impacts mutagenic and tumorigenic endpoints. Deployment of error-prone DNA repair mechanisms in lieu of high-fidelity  \nReceived: June 30, 2025. Revised: November 26, 2025. Accepted: December 21, 2025  \n© The Author(s) 2026. Published by Oxford University Press.  \nThis is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License  \n([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work i","cbCainKXYa1m9Tfq","https://ap.wps.com/l/cbCainKXYa1m9Tfq","pdf",3210603,16,"English","# Abstract\n## Introduction\n## DNA damage and repair in carcinogenesis\n## Mutation signatures and mutational portraits\n## Error-prone DNA repair and cancer genomes","[{\"question\":\"How does RAD18 influence DNA damage tolerance during replication?\",\"answer\":\"RAD18 activates Y-family trans-lesion synthesis (TLS) DNA polymerases, enabling replication across DNA damage. This process can be error-prone, affecting mutation outcomes.\"},{\"question\":\"What effect does Rad18 deficiency have in the chemically induced oral carcinogenesis model?\",\"answer\":\"In the 4NQO oral model, chronic treatment accelerates tumor onset in Rad18−/− mice versus Rad18+/+ animals. OSCC exomes show increased G(C)\\u003eT(A) transversions in Rad18−/− tumors.\"},{\"question\":\"Does Rad18 deficiency change oncogene-driven lung tumorigenesis in the KrasG12D model?\",\"answer\":\"No. Rad18 deficiency does not affect rates or incidence of oncogene-induced lung tumors or the associated mutations in this model.\"}]","Differential roles of Rad18 in repressing carcinogen-and oncogene-driven mutagenesis in vivo | PDF",1790114687,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/321e6eae67b66541d20270333cd2c5e4.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6cf8819020ef6a2593c77d62c18ebae.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0732d297af86bfb524bd5c1aa90480f8.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b3cea68006f6b53d8f37cbf4f1245383.webp",980,1268]